• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    eXoZymes Inc. - Common Stock (NQ:EXOZ)

    13.98 -0.42 (-2.92%)
    Streaming Delayed Price Updated: 9:30 AM EST, Nov 3, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,084
    Open 13.98
    Bid (Size) 12.29 (200)
    Ask (Size) 14.90 (1,600)
    Prev. Close 14.40
    Today's Range 13.98 - 13.98
    52wk Range 8.860 - 23.99
    Shares Outstanding 8,387,250
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Friday's After-Market Session
     
    Via Benzinga
    CEO of eXoZymes on 'AI in Life Sciences' panel at the Beryl Elites' Investment Conference
    Via ACCESS Newswire

    Performance

    YTD
    -21.1%
    -21.1%
    1 Month
    +5.1%
    +5.1%
    3 Month
    +40.6%
    +40.6%
    6 Month
    +28.8%
    +28.8%
    1 Year
    -21.1%
    -21.1%

    More News

    Read More
    CEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor Conference
    Via ACCESS Newswire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    CEO of eXoZymes to Present at ThinkEquity's Annual Investor Conference
    Via ACCESS Newswire
    Driving the Cell-Free Revolution: eXoZymes Leaders Join BioMADE Leadership & Technical Committees
    Via ACCESS Newswire
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    eXoZymes Provides Second Quarter 2025 Update at 5PM EST Today
    Via ACCESS Newswire
    eXoZymes to Host Second Quarter 2025 Update on Tuesday August 12, 2025, at 5PM EST
    Via ACCESS Newswire
    eXoZymes Details Biomanufacturing Breakthrough: 4 Grams of NCT with Over 99% Purity
    Via ACCESS Newswire
    eXoZymes Biomanufacturing Breakthrough: From Concept to Gram-Scale NCT in Only 5 Months
    Via ACCESS Newswire
    eXoZymes Selected as Core Industry Partner in $9M NSF-Funded Initiative to Advance Modular Cell-Free Biomanufacturing
    Via ACCESS Newswire
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    eXoZymes Highlights Scalable Biomanufacturing Platform and First Spinout, NCTx, on Grow Everything Podcast
    Via ACCESS Newswire
    eXoZymes Provides First Quarter 2025 and NCTx Subsidiary Update at 5PM EST Today
    Via ACCESS Newswire
    eXoZymes to Host First Quarter 2025 and Subsidiary NCTx Update on Monday May 12, 2025, at 5PM EST
    Via ACCESS Newswire
    eXoZymes Launches Subsidiary, NCTx, to Unlock a Promising Compound for Gut and Liver Health
    Via ACCESS Newswire
    Bringing clarity and precision to the cell-free space by introducing exozymes
    From eXoZymes Inc.
    Via GlobeNewswire
    New to The Street's FOX Business "Late Night T.V." Special Airs Tonight – Show #650 – Featuring Health In Tech CEO Julia Qian (NASDAQ:HIT), BioVie's Dr. Joseph Palumbo (NASDAQ:BIVI), eXoZymes Co-Founder & VP of Research Tyler Korman (EXOZ), and ARRIVE AI
    Via ACCESS Newswire
    BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant
    From eXoZymes Inc.
    Via GlobeNewswire
    eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO
    From eXoZymes Inc.
    Via GlobeNewswire
    eXoZymes Provides Fourth Quarter and Full Year 2024 Update
    From eXoZymes Inc.
    Via GlobeNewswire
    Earnings Scheduled For April 2, 2025
    Via Benzinga

    Frequently Asked Questions

    Is eXoZymes Inc. - Common Stock publicly traded?
    Yes, eXoZymes Inc. - Common Stock is publicly traded.
    What exchange does eXoZymes Inc. - Common Stock trade on?
    eXoZymes Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for eXoZymes Inc. - Common Stock?
    The ticker symbol for eXoZymes Inc. - Common Stock is EXOZ on the Nasdaq Stock Market
    What is the current price of eXoZymes Inc. - Common Stock?
    The current price of eXoZymes Inc. - Common Stock is 13.98
    When was eXoZymes Inc. - Common Stock last traded?
    The last trade of eXoZymes Inc. - Common Stock was at 11/03/25 09:30 AM ET
    What is the market capitalization of eXoZymes Inc. - Common Stock?
    The market capitalization of eXoZymes Inc. - Common Stock is 117.25M
    How many shares of eXoZymes Inc. - Common Stock are outstanding?
    eXoZymes Inc. - Common Stock has 117M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.